Can I Ask My Doctor for Mounjaro? (October 2026)

01 · The core answer

Can you ask your doctor for Mounjaro?

Yes, you can ask, and a polite, prepared question is entirely reasonable. Your doctor cannot promise a prescription, because NHS prescribing follows national criteria and local commissioning decisions. Mounjaro is available on the NHS, but access is being phased in over several years.⁶ A GP can only prescribe within those criteria, however strong your own wish for treatment is.

Some surgeries ask patients not to book an appointment solely to request the medicine, and instead publish their own guidance. Check your practice website or call reception first, and ask whether a routine weight-management review is the right appointment type. That saves you a wasted visit and keeps the conversation focused on your health.

The question to ask is not simply "can I have Mounjaro?" but "am I eligible under the current NHS criteria, and if not, when might that change?" That wording invites a clear answer and a next step, rather than a flat refusal.

02 · Your two decisions

The two decisions you are facing

The first decision is whether you are likely to meet the NHS criteria now. NICE recommends Mounjaro for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴ If you sit outside the earliest groups, a GP may be unable to prescribe yet.

The second decision is what you do if the answer is not yet. You can wait for the rollout to reach you, ask your GP about other weight-management support, or choose regulated private treatment. Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you want to keep reading before deciding, our guide to asking your GP covers the appointment itself, and the weight loss clinic explains the private route. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99) on the Mounjaro pen page.

03 · How to ask your GP

How to ask your GP for Mounjaro

Start by booking the right appointment and preparing a short, factual summary. Ring the surgery or use its online form, and say you would like to discuss weight management and whether newer medicines might suit you. Receptionists often triage by reason for visit, and a clear reason helps you reach the right clinician.

Before you go, gather the basics. Know your current weight, height and BMI, and write down any weight-related health conditions you have been diagnosed with. Note what you have already tried, such as structured diets, exercise programmes, group weight-management services or other medicines, and roughly how that went. Doctors make decisions from records and context, so a tidy summary saves time.

In the consultation, be direct and open. You might say: "I would like to talk about my weight and my health. I have read about Mounjaro. Am I eligible for it on the NHS, and if not, what are my options?" That is a question, not a demand, and it leaves room for the clinician to explain the criteria.

Ask these follow-ups, because they turn a refusal into a plan:

• Which NHS criteria apply to me at the moment?
• Is there a local referral pathway or specialist weight-management service?
• Can you note my interest on my record so I can be reconsidered as eligibility widens?
• Are there any health checks you would like me to have done first?

Mention anything relevant to safety, such as other medicines you take, previous pancreatitis or any history of eating disorders, pregnancy plans or breastfeeding. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed, and your clinician needs to know about that when advising you.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ Insulin and sulfonylurea doses may also need adjusting because of low blood sugar risk, so tell your doctor if you take either.

Finally, stay courteous. GPs are working within national rules and local budgets, and a calm conversation is far more likely to leave you with useful guidance. If you would like a ready-made script, our page on asking a doctor about GLP-1 medicines sets out wording you can adapt, and the related guide on asking a doctor to prescribe goes further on what a prescriber needs to hear.

04 · Who qualifies on the NHS

What medical conditions qualify for Mounjaro?

Eligibility rests on your BMI together with weight-related conditions, and the NHS is applying it in stages. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴

In plain terms, there are two layers. The licence and NICE recommendation describe who treatment is intended for. The rollout describes who the NHS can actually treat first, and that group is narrower while services build capacity. Someone can meet NICE criteria and still be told their turn has not come.

Weight-related conditions that clinicians commonly consider include type 2 diabetes, high blood pressure and sleep apnoea, though your own GP decides which diagnoses count in your case. Do not assume a condition qualifies or does not; ask the clinician to check against the current guidance for your area.

Mounjaro is licensed for weight management in adults and for type 2 diabetes.¹ People with type 2 diabetes may therefore be offered it for their diabetes through a separate NHS pathway, with its own criteria. If that applies to you, raise it at your diabetes review rather than in a weight-management appointment.

Some people with a lower BMI wonder whether they can still be considered. A private prescriber assesses suitability against the licence, and a GP is unlikely to prescribe on the NHS below the criteria. A private prescriber assesses suitability against the licence instead, and decides case by case whether treatment is appropriate. Neither route is automatic, and a consultation can end with a decision not to treat.

Ethnic background can matter in some weight-management guidance, because health risks can appear at lower BMI levels in some groups. Your clinician will know how this is applied locally, so ask directly if you think it is relevant to you.

If you are unsure where you stand, calculate your BMI, note your diagnoses and ask your GP to confirm eligibility. Our related guide on getting Mounjaro from your doctor walks through the same checks, and the weight loss medication guide covers the wider group of treatments.

05 · Why a doctor may say no

Why won't my doctor prescribe Mounjaro?

The most common reason is that you fall outside the group the NHS is currently treating. Access is being phased in over several years, and the earliest stage covers the highest-need groups first. A GP who declines is usually applying that rule, not judging you or doubting your motivation.

Other legitimate reasons exist. Your clinician may think the medicine is unsuitable because of your medical history or current medicines. It should not be used during pregnancy or while trying to conceive. The patient information lists situations where caution or avoidance is needed, and a doctor is obliged to weigh those.¹³ A refusal on safety grounds deserves a clear explanation, so ask for one.

Local capacity is another factor. Practices work with specialist services and funding that differ across the country, so two neighbouring surgeries may describe the situation differently. That is frustrating, but it reflects a phased rollout rather than a personal verdict.

When you hear no, ask four things. First, is it a no because of the criteria, or because of safety? Second, is there a pathway that would apply to me later? Third, can my interest be recorded? Fourth, what support is available now, such as dietary advice or a referral to a weight-management service?

Do not respond by trying to obtain the medicine from sellers who offer to supply without a consultation or prescription. Counterfeit and unregulated products are a real hazard, and the MHRA publishes alerts about them.⁷ Genuine treatment always involves a prescriber reviewing your health first.

You can also accept the NHS answer for now and choose a regulated private service. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. That outcome is a safeguard, not a failure.

Whatever you decide, keep your GP informed about any medicine you start, and say so at your next review. Continuity of care matters, especially if you have other conditions or take other prescriptions, and an informed GP can support you far better than one who learns about it later.

06 · What Mounjaro is

What Mounjaro is and how it works

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

Understanding the mechanism helps you talk to your doctor with confidence. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. The medicine is not a replacement for eating well and moving more; it makes that easier for many people. Your prescriber will expect you to use it alongside both.

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic). If your doctor suggests a different medicine, that is not necessarily a downgrade. Wegovy is another licensed option, and you can read about it on the Wegovy pen page. Which suits you depends on your health, tolerance and what is available to you.

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears. This matters if you plan to stop, because effects may continue to fade gradually over that period rather than ending at once.

Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.

The NHS also publishes a plain-language overview of tirzepatide for both diabetes and obesity, which is worth reading before your appointment so you can ask informed questions.⁵ Bring any questions about side effects, other medicines you take and how long treatment would be expected to last, because the clinician can answer those far better than a general web page can.

Knowing the basics also helps you spot unrealistic claims. Anyone describing tirzepatide as effortless or instant is not describing the licensed medicine, which works gradually and alongside your own efforts.

07 · Dose ladder and results

Dose steps and realistic results

Everyone starts Mounjaro on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself. After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹

Many people settle at a maintenance dose of 5mg, 10mg or 15mg — higher is not automatically better, and your prescriber will guide the right pace. If you are asking your doctor for the medicine, be ready for that answer: the dose is chosen for you, not requested.

On results, weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month. Trials measured results at 72 weeks — think in months, not days, and judge progress by trend, not individual weigh-ins.²

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone. These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Trial averages do not predict your own result.

The first weeks vary widely: some people notice appetite change and early loss in week one, others feel little until a higher dose — both are normal. Early loss includes water weight, so the trend over weeks matters more than any single weigh-in. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹

Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹¹ That review is a normal part of care, and it is worth mentioning to your GP so you both know how success will be judged.

08 · NHS versus private

NHS or private: how the routes compare

The NHS route costs nothing beyond any prescription charge, but access is phased; the private route is available sooner but you pay for the medicine. Neither is better for everyone, and the right one depends on whether you currently meet NHS criteria and what you can reasonably afford.

On the NHS, the clinician decides eligibility, and you may be asked to join a structured weight-management programme. Mounjaro is available on the NHS, but access is being phased in over several years.⁶ If you are in a prioritised group, you may be seen sooner; if not, you may wait. The NHS prescription charge in England is £9.90 per item for those who pay, though exemptions apply, so check your own position with your pharmacy.

Privately, you complete a free online consultation, and a GPhC-registered prescriber reviews it. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Dispensing is by our registered pharmacy (GPhC 9012878), and Mounjaro is supplied through official LillyDirect supply, so you receive genuine KwikPens.

On cost, standard prices before discount are £169.99 for 2.5mg, £218.99 for 5mg, £279.99 for 7.5mg and £290.99 for 10mg. If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg. A new customer's first order is £40 less, with code FIRST40, and every later order is £25 less (code DOSE25).

Across the UK pharmacies we track, Mounjaro pens range from £143.96 to £339.00 per month depending on dose and provider, checked 10 October 2026. Comparing before you commit is sensible, and our Mounjaro product page shows current doses and stock, with all doses in stock.

Payment options include Visa, Mastercard, Klarna and pay-monthly arrangements, with no subscriptions and repeat orders re-checking suitability rather than auto-shipping. Delivery is free next-day tracked in temperature-controlled packaging, with same-day dispatch when ordered by 3pm.

If you are on the NHS pathway, you do not need to choose permanently. Some people use private treatment while waiting, then tell their GP. Whichever route you take, make sure your GP knows what you are taking, so your records stay accurate and your care stays joined up. Ongoing monthly reviews and side-effect support from the prescribing team are included privately.

09 · Safety and practicalities

Safety, storage and injecting day to day

Once prescribed, the practical details are simple but worth learning before your first dose. Mounjaro is injected under the skin (subcutaneously) once a week, on the same day each week, at any time of day, with or without food. Licensed injection sites are the stomach area (at least 5cm from the belly button), the front of the thigh, or the back of the upper arm if someone else gives the injection. Rotate the site with each dose. Each KwikPen contains four weekly doses.¹

Mounjaro works the same morning or evening, with or without food. What matters is the same day each week. Many people choose a weekend morning so early side effects fall on days off. You can change your injection day if needed, as long as there are at least 3 days between two doses.¹³

If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day — never take two doses within 3 days of each other.¹³

Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use — useful for short trips — and must then be thrown away. Do not use a pen that has been above 30°C. Keep the pen cap on to protect it from light, and never use a pen that has been frozen.¹

You can fly with Mounjaro. Carry pens in hand luggage (hold luggage can fall below freezing), ideally in a cool bag with the prescription label or a copy of your prescription. Check destination rules for travelling with prescription injectables before you fly.¹

Report any suspected side effect through the Yellow Card scheme, and discuss new symptoms with your prescriber.¹⁹ Needles, a sharps bin and injection guidance come with every order from us.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹